You are here

SBIR Phase II:A Cryo-EM Automation and Intelligence Platform for Drug Discovery

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 2135832
Agency Tracking Number: 2135832
Amount: $999,956.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: DH
Solicitation Number: NSF 21-565
Solicitation Year: 2021
Award Year: 2022
Award Start Date (Proposal Award Date): 2022-02-01
Award End Date (Contract End Date): 2024-01-31
Small Business Information
United States
DUNS: 080613233
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Narasimha Kumar
 (503) 539-9528
Business Contact
 Narasimha Kumar
Phone: (503) 539-9528
Research Institution

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) PhaseII project is to improve disease research and drug discovery. Cryogenic Electron Microscopy (cryo-EM) is one of the most impactful and vital tools of biological structure analysis today.The proposed project improves the current methods to achieve better accuracy and productivity, with faster user training.The proposed project improves imaging by cryo-EM. The images currently generated by cryo-EM are highly noisy and thus requires extensive processing to build recognizable structures (proteins and others). Single-particle cryo-EM is a method that produces images of individual particles and can potentially analyze biological structures at the single-molecule level.This project uses Artificial Intelligence/Machine Learning (AI/ML) techniques to mitigate the issues.AI/ML algorithms can automate the workflow, facilitating quality data and the development of 3D models.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government